Pricing Log in Create free account

Black Diamond Therapeutics, Inc. (BDTX) vs TuHURA Biosciences, Inc. (HURA)

Black Diamond Therapeutics, Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and TuHURA Biosciences, Inc. are of similar size ($102.6M and $95.4M). Across the 10 metrics below, Black Diamond Therapeutics, Inc. leads on 8 and TuHURA Biosciences, Inc. on 2.

Valuation

Metric BDTX HURA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 1.00 5.69 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.27 n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (44.64%) (33.33%) (34.89%)
Free cash flow yield (34.04%) (28.89%) (24.52%)

Profitability

Metric BDTX HURA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) (163.84%) (50.12%)
Return on assets (29.21%) (92.31%) (45.60%)
Return on invested capital 0.00% (74.20%) 0.00%

Growth

Metric BDTX HURA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 130.71% 47.93% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDTX HURA Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 7.28 0.18 4.89
Net debt to EBITDA (10.01) 0.12 1.01

Dividend

Metric BDTX HURA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDTX HURA Biotechnology median
Market cap 95.37m 102.60m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack